LOUISVILLE, Ky. – The president of the Institute of Medicine of the National Academies will present the 2014 Leonard Leight Lecture at the University of Louisville.
Victor J. Dzau, M.D., will speak at noon, Wednesday, Dec. 10, at Kornhauser Library Auditorium on the UofL Health Sciences Campus. Admission is free.
Dzau will discuss “Molecular Approaches to Cardiac Regeneration,” an area of research being explored at UofL. Roberto Bolli, M.D., director of UofL’s Institute of Molecular Cardiology, and his colleagues have successfully shown in 19 patients who previously suffered a heart attack that their stem cells, after processing, can be re-infused back into the damaged heart muscle and improve its function.
The Leonard Leight Lecture is presented annually by the Division of Cardiovascular Medicine, also headed by Bolli, in the Department of Medicine at UofL’s School of Medicine. For 30 years until 1996, Leight was a practicing cardiologist in Louisville and played a major role in developing cardiology services and bringing innovative treatment modalities in heart disease to Louisville.
The Leonard Leight Lecture series was established in 1994 and is made possible by gifts from Dr. and Mrs. Kurt Ackermann and Medical Center Cardiologists to the Jewish Hospital & St. Mary’s Foundation.
About Victor Dzau
Dzau assumed the presidency of the Institute of Medicine July 1 after having served as chancellor for health affairs at Duke University, president and CEO for Duke University Health System, and the James B. Duke Professor, Duke University School of Medicine. He was elected to the IOM in 1988 and served on several leadership committees prior to being named president.
He has made a significant impact on medicine through his seminal research in cardiovascular medicine and genetics, his pioneering work in the discipline of vascular medicine, and recently his leadership in health care innovation.
His work on the renin angiotensin system (RAS) – a hormonal system that regulates blood pressure and fluid balance – paved the way for the contemporary understanding of RAS in cardiovascular disease and the development of RAS inhibitors as therapeutics.
Dzau also helped pioneer gene therapy for vascular disease. His most recent work provides novel insight into stem cell biology and regenerative medicine.